Floatz logo

Imiquimod

Squamous Cell Intraepithelial Neoplasia

AIDS Malignancy ConsortiumSmall moleculePhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Squamous Cell Intraepithelial Neoplasia cohort.

Asset / SponsorPhaseRating
Fluorouracilum
AIDS Malignancy Consortium
Phase 3BB

Same molecule, other indications

Imiquimod is also rated in:

lentigo maligna melanomaDormant
BBB
Indicative · Phase 4
77 / 100
View asset →
human papilloma virus infectionDormant
B
Indicative · Phase 3
63 / 100
View asset →
melanomaActive
B
Indicative · Phase 2
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →